ArticleIntestinal research2023

Concomitant ankylosing spondylitis can increase the risk of biologics or small molecule therapies to control inflammatory bowel disease.

Yu Kyung Jun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.